Lucid Diagnostics (LUCD) Receivables - Other (2020 - 2023)

Lucid Diagnostics' Receivables - Other history runs 4 years deep, the most recent figure standing at $10.7 million for Q2 2023.

• Quarterly Receivables - Other rose 340.39% year-over-year to $10.7 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $10.7 million (up 340.39% YoY) and the FY2022 annual result came in at $5.0 million, up 199.34% from the prior year.
• Receivables - Other was $10.7 million for Q2 2023 at Lucid Diagnostics, up from $7.6 million in the prior quarter.
• Across five years, Receivables - Other topped out at $13.3 million in Q4 2020 and bottomed at $1.7 million in Q4 2021.
• A 4-year average of $6.1 million and a median of $5.8 million in 2022 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2021 — Receivables - Other slumped 87.5% — and 2023, when it surged 340.39%.
• Lucid Diagnostics' Receivables - Other stood at $13.3 million in 2020, then slumped by 87.5% to $1.7 million in 2021, then jumped by 199.34% to $5.0 million in 2022, then surged by 115.67% to $10.7 million in 2023.
• Business Quant data shows LUCD's Receivables - Other at $10.7 million in Q2 2023, $7.6 million in Q1 2023, and $5.0 million in Q4 2022.